NCIRS COVID-19 response

AusVaxSafety is conducting comprehensive active safety monitoring of all COVID-19 vaccines used in Australia to ensure that the vaccines are safe and to provide transparent data to healthcare providers and the public. 

Using its established active surveillance system, AusVaxSafety monitors adverse events following immunisation in people who receive a COVID-19 vaccine. This helps facilitate early detection of any potential vaccine safety issues in near-real time through responses to a brief survey sent via an automated SMS or email in the days following vaccination. These surveys give participants the opportunity to report any adverse events they have after receiving the COVID-19 vaccine. Since the start of the COVID-19 vaccination program in February 2021, AusVaxSafety has analysed more than 1 million survey responses.

AusVaxSafety is working closely with the Therapeutic Goods Administration (TGA), the COVID-19 Vaccine Taskforce of the Australian Government, and state and territory health departments to ensure that monitoring of COVID-19 vaccine safety is of the highest possible standard in Australia.

Visit AusVaxSafety website to read more about COVID-19 vaccine safety surveillance.

Access the latest COVID-19 vaccine safety data here

 

Last updated April 2023